Lupin signs an agreement with National Chemical Laboratory & DST

Simple item page
dc.date.accessioned2018-06-06T09:22:43Z
dc.date.available2026-02-19T08:53:37Z
dc.date.issued2018-03-08
dc.descriptionPharma major Lupin has signed an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for conducting research on a continuous purification process development of a biosimilar monoclonal antibody therapeutic (mAb). Through this research collaboration, CSIR-NCL and Lupin would together work towards the development of a novel continuous purification process for manufacturing mAb therapeutics.en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12252/3941
dc.language.isoenen_US
dc.publisherTimes of Indiaen_US
dc.subjectContinuous Purification Process Developmenten_US
dc.subjectBiosimilar Monoclonal Antibody Therapeuticen_US
dc.subjectControlled Chromatography Processesen_US
dc.subjectBiopharmaceuticalsen_US
dc.subjectBiologicsen_US
dc.subjectMonoclonal Antibodiesen_US
dc.titleLupin signs an agreement with National Chemical Laboratory & DSTen_US
dc.typeNewspaper Articleen_US
local.division.divisionChemical Engineering and Process Development Division

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Lupin signs research pact with CSIR-NCL, Dept of Science &Tech - Times of India.pdf
Size:
314.53 KB
Format:
Adobe Portable Document Format
Description:
Lupin collaborated with NCL & DST
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Newspaper Clippings